Event content

Device reusability has gained increasing attention in recent years, owing toits potential to reduce both the costs and environmental impact of drug delivery devices. This has made reusable autoinjectors an appealing and potentially more sustainable option, especially when considering chronic conditions whi...

Global markets are increasingly penalizing linear business models that harm the environment and society, making a strong case for sustainable practices. In pharmaceutical packaging, this shift demands rethinking strategies to maximize resource efficiency while protecting human and planetary health. As pack...

The current exemptions from PPWR and the like which are afforded to pharma packaging won't last forever. In this session we shall explore sustainable solutions that are being delivered industry wide, as well as considering specific material changes which can reduce overall carbon emissions.

Contract Packaging Organizations (CPOs) and Contract Development and Manufacturing Organizations (CDMOs) play critical roles in the pharmaceutical supply chain. Their strategic visions are shaped by evolving industry demands, technological advancements, and regulatory requirements. • This panel will h...

Developing purification protocols can be challenging for molecules beyond traditional mAbs such as bispecific antibodies, antibody fragments, and other recombinant proteins. Here we cover strategies to help simplify purification of some of these trickier molecules. This presentation covers: • Aspects o...

Traditional biologics manufacturing relies on batch processing, which involves sequential operations and faces significant limitations, such as low productivity, lengthy processing times, and high operational costs due to large infrastructure needs and frequent manual interventions. To overcome these chall...

In today’s globalized economy, international integration plays a crucial role in the development of new molecules. This integration encompasses various aspects, including the transfer of production activities and the utilization of past experiences. • Risk and Innovation: The development of APIs (active...

Leveraging Data Analytics for Build a More Resilient Supply Chain. Today, patients in the United States and around the world depend on medicines—and the ingredients used to make those medicines—sourced from and manufactured around the globe. The recent pandemic, geopolitical, and natural events have not on...

One of the problems that today US suffers is the persistent shortages in pharmaceuticals. The concentration of key products in countries as China and India is a risk for the United States and a necessity to diversify and include new partners. Special efforts are needed to have supply chain resiliency. M...

Antibody-drug conjugates (ADCs) are pioneering biologics that merge antibodies’ specificity with small molecules’ potency. With a handful of FDA-approved ADCs in the market and many under development, ADCs are poised to revolutionize therapeutics. This talk examines the complexities of ADC production, emph...

The Pharma and Life Sciences industry confronts a pressing challenge—a substantial talent shortage compounded by the effects of the Great Resignation. To remain competitive and seize emerging opportunities, companies must prioritize both external hiring and internal mobility strategies. This pivotal issue ...

Per- and polyfluoroalkyl substances (PFAS) have long been integral in pharmaceutical packaging due to their unique properties. However, emerging regulatory changes in both the United States and the European Union have signaled a pivotal shift in the use of PFAS materials, particularly in pharmaceutical pac...

Edge Technologies, based on RFID (Radio Frequency Identification) and NFC (Near Field Communication) give medical devices and medicines a unique digital identity, and automatically read, sense, store and process, data locally on products, whilst enabling tracking and complex processing in the cloud or priv...

Meet industry sustainability experts in an informal setup for an open discussion on what matters the most for you as part of the Pharma industry. What are your current sustainability planning issues and how could you solve them? What could be your next steps and with whom do you need to collaborate to reac...

In this presentation, attendees will learn about the profound impact of pre-sterilized and pre-washed vials, commonly known as ready-to-use (RTU) vials, on enhancing patient safety. The speech emphasizes how RTU vials contribute to a reduction in contamination risks, thereby decreasing the potential for pr...

The European region has historically maintained a prominent role in global off-patent API manufacturing. However, it is apparent that unique constraints are linked to API manufacturing in the European market. In this presentation, we will delve into:
• Exploring the challenges and opportunitie...

The pharmaceutical industry faces significant challenges in bringing new drugs to market due to the complexities of the R&D process. These challenges include high costs, lengthy development timelines, and a low success rate. In response to these challenges, a new approach to R&D has emerged: R&D 4.0. qq...

Join us, where Ferenc Marofka rom the European Commission will provide an overview of the Drug Formulation market in Europe

Pharmaceutical and other healthcare innovations have extended and improved countless lives in recent decades. Today, advanced manufacturing technologies such as pharmaceutical continuous manufacturing are gaining increasing interest for their potential to serve as one more way to improve global health by b...

With constraints on clinical supplies due to high demand, the industry is scrambling to find a solution. Join our focused panel, where our experts will offer insights and tips for designing a supply chain to help meet current supply needs: • Investing in smarter processes and forecasting technology to ...

In pharma, it is essential to identify the right partner to ensure a successful outcome. Time and time again, mistakes have been made in this process, causing clinical studies to fail and for the company to take a heavy hit. Want to avoid this? join our one-hour masterclass where we will devise a checklist...

Companies must have the right partner to avoid potential setbacks in clinical development. To avoid disappointment, join our panel and gain expert analysis and best practices in sourcing the right CDMO for your study: • Strategies for getting the most out of our CDMO partnership – mapping objectives, d...

Lyophilization (freeze drying) is a proven process for increasing the shelf life of vaccines, biologics and other injectables. But delivering these products requires several use steps that make them challenging to administer, particularly by patients and caregivers in non-clinical settings. To address thes...

Packaging is an integral part of the design for pharmaceutical products and medical devices. Not only does one need to take into account the look, feel, and protective qualities of the packaging but design must be considered when determining the sterilization technology. Determining the sterilization techn...

Sub-optimal adherence and persistence to treatment continue to be significant challenges for both on-market drugs and investigational products in clinical development. This is especially true for self-administered medications for chronic disease patients, hence driving the need for improved treatment intak...

Ability to achieve successful injection of drug or biologic depends on many factors including but not limited to needle diameter, drug viscosity, spring force, lubrication, plunger geometry and material properties. One additional challenge to be considered during verification of the drug delivery system i...

In this session you hear from Johannes Galatsanos, Head of Data - Lean Digital Core ERP Transformation from Novartis.

Technological innovation in Pharma and Life Science is happening now!

Metaverse, Artificial Intelligence, Data Analytics, Machine Learning, Digitalization: these topics are ranking high on the agenda of the business leaders who understand the competitive advantages that can be seized by moving n...

When working with the right partner and network, transferring production between sites allows companies to reap a variety of strategic advantages. Timeline and cost efficiencies can be gained when a trusted CDMO can take a product from development to commercial launch.

They can safeguard supply ...

Resyca, a joint venture between Recipharm and Medspray, is developing a novel type of soft mist inhaler devices, based on an existing primary packaging: glass pre filled syringes. This way we can utilise existing filling lines within Recipharm to do the aseptical filling. The lecture will describe the devi...

In this webinar, originally broadcast as part of the Pharmapack Europe show, Tom Oakley, Director of Drug Delivery Device Development, Springboard discusses 'Top Strategies for Environmental Sustainability with Examples'. Environmental sustainability is the defining challenge of our time. Whereas most glob...

In this webinar, originally broadcast as part of the Pharmapack Europe show, Stefan Lutzmayer, Consultant, IQVIA discusses how as biologics and specialty medicines increase in importance in global healthcare, especially when access to medicines and biosimilars become growth areas, this brings various oppor...

In this webinar, originally broadcast as a part of Pharmapack Europe 2022, Mayur Patel, Digital Health Expert, PA Consulting discusses in this session how every day 14,000 tons of medical waste are generated at healthcare facilities across the U.S. alone. Up to 20-25% of this waste can be attributed to pl...

In this webinar, originally broadcast as a part of Pharmapack Europe, Eve-Marie Vaccaro, Global Sales & Operation Planner, and Edgar Bauer, Global Key Account Manager Bausch+Ströbel from BD Medical - Pharmaceutical Systems discuss how VHP sterilization is a viable alternative for ensuring improved patient ...

The webinar addresses the need for new modalities, evolution of bio manufacturing of new modalities, and comparison with semiconductor manufacturing. This session was broadcast as part of the CPHI North America show.

As global governments and businesses increasingly make bold claims and commitments to tackle the climate emergency, investors are starting to take note by using the ESG framework to move beyond environmental concerns and focus on a company's impact on all the different ecosystems it operates in. The ris...

Merger, acquisition, and consolidation activity in CRO/CDMO world has intensified to the point where many of my colleagues are beginning to wonder how big the global players can actually become. While many of the mid-sized players have disappeared, a huge number of small pharma service organizations are th...

In this webinar, originally broadcast as part of CPHI North America 2022, Frances Zipp, President and CEO, Lachmann Consultants Services discusses lessons learned and best practices for these relationships that can be applied to both accelerated approvals as well as “normal” drug supply during non-pandemic...